DAXXIFY
Revance Therapeutics, Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88984738 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Maren C. Perry |
| Attorney Docket Number | 13720.104073 |
| Law Office Assigned | N70 |
| Employee Name | KETCHUM, BRENDAN J |
Timeline
| 2020-03-30 | Application Filed |
| 2020-07-28 | Published for Opposition |
| 2022-09-26 | Date of First Use |
| 2022-10-24 | Location: TMO LAW OFFICE 125 |
| 2022-10-24 | Status: Live/Pending |
| 2022-10-24 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Revance Therapeutics, Inc. |
| Address | 7555 Gateway Blvd. Newark DE 94560 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the treatment of wrinkles |
| GS0051 | Pharmaceutical preparations for the treatment of wrinkles |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2020-04-02 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-04-04 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2020-06-19 | 3 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-06-19 | 4 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-07-08 | 5 NONP E:E-Mail |
| TEAS POST PUBLICATION AMENDMENT RECEIVED | 2020-07-16 | 6 EPPA I:Incoming Correspondence |
| PUBLISHED FOR OPPOSITION | 2020-07-28 | 7 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-07-28 | 8 NPUB E:E-Mail |
| ASSIGNED TO PETITION STAFF | 2020-08-06 | 9 APET A:Allowance for Publication |
| CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED | 2020-08-06 | 10 CHPB I:Incoming Correspondence |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-09-22 | 11 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2021-02-15 | 12 EEXT I:Incoming Correspondence |
| SOU EXTENSION 1 FILED | 2021-02-15 | 13 EXT1 S: |
| SOU EXTENSION 1 GRANTED | 2021-02-15 | 14 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-02-17 | 15 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2021-09-01 | 16 EEXT I:Incoming Correspondence |
| SOU EXTENSION 2 FILED | 2021-09-01 | 17 EXT2 S: |
| SOU EXTENSION 2 GRANTED | 2021-09-01 | 18 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-09-03 | 19 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2022-03-02 | 20 EEXT I:Incoming Correspondence |
| SOU EXTENSION 3 FILED | 2022-03-02 | 21 EXT3 S: |
| SOU EXTENSION 3 GRANTED | 2022-03-02 | 22 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-03-04 | 23 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2022-08-31 | 24 EEXT I:Incoming Correspondence |
| SOU EXTENSION 4 FILED | 2022-08-31 | 25 EXT4 S: |
| SOU EXTENSION 4 GRANTED | 2022-08-31 | 26 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-09-02 | 27 EXRA E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2022-10-07 | 28 EISU I:Incoming Correspondence |
| TEAS REQUEST TO DIVIDE RECEIVED | 2022-10-07 | 29 ERTD I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2022-10-24 | 30 AITU A:Allowance for Publication |
| DIVISIONAL REQUEST RECEIVED | 2022-10-07 | 31 DRRR I:Incoming Correspondence |
| DIVISIONAL PROCESSING COMPLETE | 2022-10-24 | 32 DPCC D:Assigned to Examiner |
| USE AMENDMENT FILED | 2022-10-07 | 33 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2022-10-24 | 34 SUPC I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2022-11-17 | 35 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2022-11-18 | 36 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2022-12-20 | 37 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2022-12-20 | 38 NRCC E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 DAXXIFY 97809052 not registered Live/Pending |
Revance Therapeutics, Inc. 2023-02-23 |
 DAXXIFY 88984738 not registered Live/Pending |
Revance Therapeutics, Inc. 2020-03-30 |
 DAXXIFY 88852845 not registered Live/Pending |
Revance Therapeutics, Inc 2020-03-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 